Botox, Containment and FDA Approval - Clinical Research Informer

GW Pharma Hopes to Bring Its Second Cannabis-Based Drug to Market in the U.S.

The Pharma Data

NOVEMBER 2, 2020

Nabiximols is a complex botanical medicine formulated from extracts of the cannabis plant that contains the principal cannabinoids THC and CBD and also contains minor constituents, including other cannabinoid and non-cannabinoid plant components, such as terpenes, sterols and triglycerides, according to company data.

FDA Approval

FDA Approval Drugs Marketing Botox

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

AUGUST 2, 2023

Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. It contains the antiviral medications nirmatrelvir and ritonavir. In addition, the FDA approved Pfizer’s pneumococcal 20-valent conjugate vaccine, Prevnar 20, for the first time in June 2021.

Sales

Sales Manufacturing FDA Approval Life Science

Clinical Research Informer

GW Pharma Hopes to Bring Its Second Cannabis-Based Drug to Market in the U.S.

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

Webinars

Stay Connected